| Issue Date | Title | Author(s) |
| 2020-10 | Development and implementation of blood pressure screening and referral guidelines for German community pharmacists. | Schulz, M; Griese-Mammen, N; Schumacher, PM; Strauch, D; Freudewald, L; Said, A; Tsuyuki, RT; Laufs, U; Kintscher, U; Böhm, M; Mahfoud, F |
| 2017-12-01 | Do patients with diabetes type 2 or chronic heart failure understand a medication plan? | Botermann, L; Wachter, A; Monzel, K; Krueger, K; Ewen, S; Mahfoud, F; Griese-Mammen, N; Schulz, M; Laufs, U |
| 2016-10 | Evaluating patients' comprehensibility of a standardized medication plan. | Botermann, L; Monzel, K; Krueger, K; Eickhoff, C; Wachter, A; Kloft, C; Laufs, U; Schulz, M |
| 2021-10 | Impact of angiotensin receptor blocker product recalls on antihypertensive prescribing in Germany. | Rudolph, UM; Enners, S; Kieble, M; Mahfoud, F; Böhm, M; Laufs, U; Schulz, M |
| 2018-01 | In search of a standard when analyzing medication adherence in patients with heart failure using claims data: a systematic review. | Krueger, K; Griese-Mammen, N; Schubert, I; Kieble, M; Botermann, L; Laufs, U; Kloft, C; Schulz, M |
| 2021 | Interdisciplinary Physician-Pharmacist Medication Review for Outpatients With Heart Failure: A Subanalysis of the PHARM-CHF Randomized Controlled Trial. | Schumacher, PM; Griese-Mammen, N; Schneider, J; Laufs, U; Schulz, M |
| 2020-03 | Letter on 'Pharmacy-based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM-CHF randomized controlled trial': reply. | Schulz, M; Griese-Mammen, N; Böhm, M; Laufs, U |
| 2016-10-01 | Medication adherence and persistence according to different antihypertensive drug classes: A retrospective cohort study of 255,500 patients. | Schulz, M; Krueger, K; Schuessel, K; Friedland, K; Laufs, U; Mueller, WE; Ude, M |
| 2016 | Medication knowledge of patients hospitalized for heart failure at admission and after discharge. | Custodis, F; Rohlehr, F; Wachter, A; Böhm, M; Schulz, M; Laufs, U |
| 2018-09 | PHARMacy-based interdisciplinary program for patients with Chronic Heart Failure (PHARM-CHF): rationale and design of a randomized controlled trial, and results of the pilot study. | Laufs, U; Griese-Mammen, N; Krueger, K; Wachter, A; Anker, SD; Koehler, F; Rettig-Ewen, V; Botermann, L; Strauch, D; Trenk, D; Böhm, M; Schulz, M |
| 2022-12 | Sacubitril/valsartan in heart failure: efficacy and safety in and outside clinical trials. | Abdin, A; Schulz, M; Riemer, U; Hadëri, B; Wachter, R; Laufs, U; Bauersachs, J; Kindermann, I; Vukadinović, D; Böhm, M |
| 2020-07-23 | The impact of pharmacist/physician care on quality of life in elderly heart failure patients: results of the PHARM-CHF randomized controlled trial. | Schulz, M; Griese-Mammen, N; Schumacher, PM; Anker, SD; Koehler, F; Ruckes, C; Rettig-Ewen, V; Wachter, R; Trenk, D; Böhm, M; Laufs, U |
| 2022 | Trends in Ezetimibe Prescriptions as Monotherapy or Fixed-Dose Combination in Germany 2012-2021. | Katzmann, JL; Kieble, M; Enners, S; Böhm, M; Mahfoud, F; Laufs, U; Schulz, M |
| 2022-02-27 | Use of fixed-dose combination antihypertensives in Germany between 2016 and 2020: an example of guideline inertia. | Mahfoud, F; Kieble, M; Enners, S; Kintscher, U; Laufs, U; Böhm, M; Schulz, M |
| 2021-11 | Utilization of drugs with reports on potential efficacy or harm on COVID-19 before, during, and after the first pandemic wave. | Enners, S; Gradl, G; Kieble, M; Böhm, M; Laufs, U; Schulz, M |
